v3.26.1
SEGMENT REPORTING (Details) - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Segment Reporting Information [Line Items]    
Sales $ 1,363,045 $ 0
Cost of goods sold 180,625 0
Total operating expenses 14,225,918 10,054,488
Net (loss) gain from operations (13,043,498) (10,054,488)
Biotechnology Segment [Member]    
Segment Reporting Information [Line Items]    
Sales 0 0
Cost of goods sold 0 0
Total operating expenses 13,540,971 10,054,488
Net (loss) gain from operations (13,540,971) (10,054,488)
Technology Segment [Member]    
Segment Reporting Information [Line Items]    
Sales 1,363,045 0
Cost of goods sold 180,625 0
Total operating expenses 684,947 0
Net (loss) gain from operations $ 497,473 $ 0